|
Letter from the Editor |
Did You Know? |
Thought of the Week |
IJPC now on Facebook and Youtube |
Looking Back |
|
|
|
Info@CompoundingToday.com or (800) 757-4572 ext 1 |
|
|
To place a classified advertisement please contact: Lauren Bernick lbernick@ijpc.com or (405) 513-4236 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 | |  |
| The FDA and Pharmacy Compounding FDA Form 483, Part 13 |
|
FDA 483 Observations in 503B Outsourcing Facilities
In this issue, we will continue our review of FDA 483 observations in 503B outsourcing facilities; specifically, we will look at two categories of observations: "Environmental Monitoring" and "Cleaning, Disinfecting, and Deactivation."
ENVIRONMENTAL MONITORING (EM)
- Your firm failed to conduct investigations related to all mold recoveries during environmental monitoring.
- Your firm failed to conduct surface samples as outlined in your firm's written procedure.
- Your firm failed to justify the reduction of environmental monitoring frequencies of yeast and mold plates per your firm's written procedure.
- Your firm's written procedure for EM during aseptic operations is not representative of your firm's most challenging and/or stressful conditions.
- The firm does not have scientific justification for not monitoring environmental conditions throughout manufacturing operations with the ISO-5 LAF hood.
- The firm does not monitor the differential pressure of the ISO-5 LAF hood during manufacturing operations.
- Non-viable air sampling is not conducted during production.
- An unclassified room utilized during the production of sterile drug products, does not undergo routine environmental monitoring.
- Alarm systems to monitor for potential breaches in air quality are currently not employed.
- Alarms for monitoring the pressure differentials for the cleanroom are not handled according to the firm's written procedure.
- The monitoring for non-viable particulates is not located in close proximity to the aseptic operator.
CLEANING, DISINFECTING, AND DEACTIVATION
- Aseptic processing areas are deficient regarding the system for cleaning and disinfecting the room and equipment to produce aseptic conditions.
- Your firm has not established a cleaning validation to assure your cleaning process removes chemical and microbial residues on the equipment used in your aseptic operations.
- Your ISO-5 cleaning procedure does not address cleaning the inside of the acrylic view screens and front surfaces with the ISO-5 laminar air flow space.
More next week.
|
Loyd V. Allen, Jr., PhD, RPh
Editor-in-Chief
International Journal of Pharmaceutical Compounding
Remington: The Science and Practice of Pharmacy Twenty-second edition
|
|
Did You Know (On Hope)...
...that Norman Vincent Peale stated the following?
"Hope is wishing for a thing to come true; faith is believing that it will come true."
|
|
Thoughts of the Week (On Hope)
"There is not enough darkness in the world to put out the light of one small candle." (Anon)
"Totally without hope one cannot live. To live without hope is to cease to live. Hell is hopelessness. It is no accident that above the entrance to Dante's hell is the inscription "leave behind all hope, ye who enter here." (Fyodor Dostoyevsky)
Dr. Victor Frankl, an Austrian psychiatrist observed that a prisoner did not continue to live very long after hope was lost. But, even the slightest ray of hope-the rumor of better food, a whisper about an escape-helped some of the camp inmates to continue living even under systematic horror. (Man's Search for Meaning). (G. Sweeting)
|
|
Spread the word ...
... forward this newsletter to someone that needs it.
Tell them they can get their own free copy of the weekly Compounding Today newsletter at
https://CompoundingToday.com/Newsletter/
|
|
|
Looking Back
Clancy's whiskers
Tickle Nancy
Nancy lowered the boom,
On Clancy!
Burma-Shave
|
|
|
|
|
|